Comprehensive Subcutaneous Immunoglobulin (SCIG) Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034

What industry-specific factors are fueling the growth of the subcutaneous immunoglobulin (scig) market?
The rise in secondary immunodeficiency diseases is expected to drive the growth of the subcutaneous immunoglobulin market. Secondary immunodeficiency diseases, caused by factors such as aging populations and immunosuppressive treatments, reduce immune function. Subcutaneous immunoglobulin therapy helps strengthen the immune system by providing necessary antibodies. The UK Health Security Agency reported in October 2023 that new HIV diagnoses in England increased by 22% in 2022, which will support the subcutaneous immunoglobulin market.

Get Your Subcutaneous Immunoglobulin (SCIG) Market Report Here:
https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

What Is the projected market size and growth rate for the subcutaneous immunoglobulin (scig) market?
The subcutaneous immunoglobulin (SCIG) market has seen rapid growth and is expected to rise from $12.72 billion in 2024 to $14.52 billion in 2025, with a CAGR of 14.1%. This growth is driven by the rising prevalence of immunodeficiency disorders, patient preference for home-based care, better therapeutic effectiveness, increased awareness, and favorable reimbursement policies.

The subcutaneous immunoglobulin (SCIG) market is projected to reach $24.29 billion by 2029, growing at a CAGR of 13.7%. Growth is driven by the rising prevalence of neurological and autoimmune disorders, greater acceptance of immunoglobulin therapy, expanding applications in neurology and dermatology, and increasing healthcare facilities. Key trends include advancements in drug delivery systems, home infusion therapy demand, antibody therapy innovations, and SCIG formulation improvements.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15935&type=smp

What new trends are reshaping the subcutaneous immunoglobulin (scig) market and its opportunities?
In the subcutaneous immunoglobulin market, companies are developing unique formulations like subcutaneous human-klhw to strengthen the immune system. For instance, in March 2022, Grifols launched XEMBIFY 20% subcutaneous immunoglobulin (SCIG), designed to treat primary immunodeficiency diseases. This formulation is stable at room temperature for up to 24 months, simplifying treatment and improving patient convenience by avoiding refrigeration during storage and transport.

What major market segments define the scope and growth of the subcutaneous immunoglobulin (scig) market?
The subcutaneous immunoglobulin (SCIG) market covered in this report is segmented -

1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)
2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications
3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses

Subsegments:
1) By Immunoglobulin A (IgA): IgA1, IgA2
2) By Immunoglobulin G (IgG): IgG1, IgG2, IgG3, IgG4
3) By Immunoglobulin M (IgM): Pentameric IgM, Hexameric IgM

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15935

Which regions are key players in the growth of the subcutaneous immunoglobulin (scig) market?
North America was the largest region in the subcutaneous immunoglobulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (SCIG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which key market leaders are driving the subcutaneous immunoglobulin (scig) industry growth?
Major companies operating in the subcutaneous immunoglobulin (SCIG) market are Pfizer Inc., Johnson & Johnson, Prothena Corporation plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Baxter International Inc., CSL Behring, Lonza Group, Grifols S.A., Octapharma AG, Dr. Reddy's Laboratories, Intas pharmaceutical Ltd., Emergent BioSolutions Inc., Kedrion Biopharma, LFB group, Biotest AG, Argenx SE, Bio Products Laboratory Ltd., ADMA Biologics Inc., Sino Biological Inc., Bharat Serums and Vaccines Limited (BSV), Kamada Pharmaceuticals, CinnaGen Co., Shire plc

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15935&type=smp

What Is Covered In The Subcutaneous Immunoglobulin (SCIG) Global Market Report?

•Market Size Forecast: Examine the subcutaneous immunoglobulin (scig) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the subcutaneous immunoglobulin (scig) market for a structured understanding.
•Key Players Overview: Analyze major players in the subcutaneous immunoglobulin (scig) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the subcutaneous immunoglobulin (scig) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the subcutaneous immunoglobulin (scig) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the subcutaneous immunoglobulin (scig) market.
•Industry Challenges: Identify potential risks and obstacles affecting the subcutaneous immunoglobulin (scig) market.
•Competitive Landscape: Review strategic developments in the subcutaneous immunoglobulin (scig) market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.